Simon Tual-Chalot

Newcastle University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Jason Gill

Reader in Molecular Therapeutics

Newcastle University

UNITED KINGDOM

View details

John Henry Dark

Professor of Cardiothoracic Surgery

UNITED KINGDOM

View details

Aikaterini Gatsiou

University of Lancaster

UNITED KINGDOM

View details

Ioakim Spyridopoulos

Newcastle University

UNITED KINGDOM

View details

Livia de Lucca Camargo

Research Institute of the McGill University Health Centre

CANADA

View details

Konstantinos Stellos

Professor of Medicine & Director

Ruprecht Karls Universität Heidelberg

GERMANY

View details

Guy MacGowan

Hon Professor of Heart Failure

Newcastle University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Simon Tual-Chalot

Research Interests

Explore related searches

Contact this professor

Articles (10)

Exogenous Transforming Growth Factor-β1 and Its Helminth-Derived Mimic Attenuate the Heart's Inflammatory Response to Ischemic Injury and Reduce Mature Scar Size

Identifying optimal reference genes for real-time quantitative polymerase chain reaction in human myocardial tissues

Mechanisms of Vascular Inflammation and Potential Therapeutic Targets: A Position Paper From the ESH Working Group on Small Arteries

Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury

Author Correction: Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction

Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction

Targeting the adipose tissue: heart crosstalk in pressure overload-induced heart failure

Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction

Drug repurposing to prevent pressure overload-induced cardiac hypertrophy and heart failure.

Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis.

Collaborators (7)

Jason Gill

John Henry Dark

Aikaterini Gatsiou

Ioakim Spyridopoulos

Livia de Lucca Camargo

Konstantinos Stellos

Guy MacGowan

Make your next move.